Table 1.
Characteristics | Number of patients | P-value* | ||
---|---|---|---|---|
Low CDK7 expression | High CDK7 expression | |||
Gender | Male | 27 | 26 | 0.684 |
Female | 24 | 19 | ||
Age | ≤60 | 31 | 22 | 0.305 |
>60 | 20 | 23 | ||
Tumor size | ≤5cm | 25 | 12 | 0.035 |
>5cm | 26 | 33 | ||
CA19-9, kU/L | ≤37 | 28 | 17 | 0.105 |
>37 | 23 | 28 | ||
TBIL, µmol/L | ≤ 34.4 | 40 | 38 | 0.602 |
>34.4 | 11 | 7 | ||
TNM stage | I/II | 29 | 14 | 0.014 |
III/IV | 22 | 31 | ||
T stage | I/II | 38 | 28 | 0.27 |
III/IV | 13 | 17 | ||
Lymphatic metastasis | Positive | 13 | 18 | 0.189 |
Negative | 38 | 27 | ||
Distant metastasis | Positive | 7 | 9 | 0.291 |
Negative | 44 | 36 | ||
Vascular invasion | Positive | 9 | 8 | 1 |
Negative | 42 | 37 | ||
Nerve invasion | Positive | 6 | 7 | 0.766 |
Negative | 45 | 38 |
* Chi-square test.